Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,536,379
-
Share change
-
+3,843,496
-
Total reported value
-
$35,245,078
-
Put/Call ratio
-
1.1%
-
Price per share
-
$1.28
-
Number of holders
-
46
-
Value change
-
+$4,822,929
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q1 2024
As of 31 Mar 2024,
AVROBIO INC - COM (AVRO) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,536,379 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, BML Capital Management, LLC, ADAR1 Capital Management, LLC, Verition Fund Management LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Newtyn Management, LLC, Aisling Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, and TANG CAPITAL MANAGEMENT LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.